Surgical Treatment for Spasticity: Selective Dorsal Rhizotomy ­ Technique and Literature Review

Spasticity is amotor disorder that leads to a resistance to passive jointmovement. Cerebral palsy is the most important cause of spasticity and can be caused by several factors, including multiple gestations, alcoholism, infections, hemorrhages, drowning, and traumatic brain injuries, among others. There aremany scales that help tomeasure andmonitor the degree of impairment of these patients. The initial treatment should focus on the causal factor, such as tumors, inflammation, degenerative diseases, hydrocephalus, etc. Subsequently, the treatment of spastic musculature includes oral or intrathecal myorelaxants, spinal cord electrostimulation, neurotomies, Lissauer tract lesion, dentatotomy and selective dorsal rhizotomy. The latter is a safetechnique, possibleto beperformed inmost centers with neurosurgical support, and it is effective in the treatment of severe spasticity. In this article, the authors describe the surgical technique and conduct a review the literature.

Self-Powered Direct Muscle Stimulation Using a Triboelectric Nanogenerator (TENG) Integrated with a Flexible Multiple-Channel Intramuscular Electrode.

Muscle function loss can result from multiple nervous system diseases including spinal cord injury (SCI), stroke, and multiple sclerosis (MS). Electrical muscle stimulation is clinically employed for rehabilitative and therapeutic purpose and typically requires mA-level stimulation current. Here, we report electrical muscle stimulation, which is directly powered by a stacked-layer triboelectric nanogenerator (TENG) through a flexible multiple-channel intramuscular electrode. This multiple-channel intramuscular electrode allows mapping of motoneurons that is sparsely distributed in the muscle tissue and thus enables high efficiency TENG muscle stimulation, although the short-circuit current of the TENG is only 35 µA. With a stimulation efficiency matrix, we find the electrical muscle stimulation efficiency is affected by two factors, namely, the electrode-motoneuron position, and the stimulation waveform polarity. To test whether it is a universal phenomenon for electrical stimulation, we then further investigate with the conventional square wave current stimulation and confirm that the stimulation efficiency is also affected by these two factors. Thus, we develop a self-powered direct muscle stimulation system with a TENG as power source and waveform generator, and a multiple-channel intramuscular electrode to allow motoneuron mapping for stimulation efficiency optimization. We believe such self-powered system could be potentially used for rehabilitative and therapeutic purpose to treat muscle function loss.

Multidisciplinary approach and anesthetic management of a surgical cancer patient with methylene tetrahydrofolate reductase deficiency: a case report and review of the literature.

INTRODUCTION: Hyperhomocysteinemia is a known risk factor for myocardial infarction, stroke, peripheral vascular disease, and thrombosis. Elevated plasma homocysteine levels have been demonstrated in patients with recurrent episodes or a single episode of thrombosis. Here we describe the development of cardiovascular disease as a complication of a surgical intervention in a patient with colorectal cancer and hyperhomocysteinemia. CASE PRESENTATION: A 65-year-old Caucasian man complained of pain and constipation, attributed to previously diagnosed adenocarcinoma (stage IIB) of the hepatic flexure. An anamnestic investigation showed that he had undergone two surgical interventions. During both, he suffered thrombotic postoperative complications, a deep vein thrombosis of the upper extremity after the first operation and retinal vein occlusion after the second. He was diagnosed with hyperhomocysteinemia associated with a homozygous C677T mutation of the gene encoding the enzyme methylenetetrahydrofolate reductase. Our patient was initially treated with folic acid and high-dose B vitamins. On day 7 he underwent a right hemicolectomy. Anesthesia was performed with sevoflurane in 40% O2 and without the use of nitrous oxide. Postoperatively, our patient remained on folic acid and B vitamins and was without immediate or subsequent complications. CONCLUSIONS: Neoplastic disease and related surgery followed by the administration of chemotherapeutic drugs alter the hemostatic balance in cancer patients. Those suspected of also having a thrombophilic disease require a thorough laboratory diagnostic workup, including a molecular analysis aimed at identifying the genetic mutation responsible for the hyperhomocysteinemia, as indicated. The case described in this report highlights the importance of a multidisciplinary approach that includes expertise in peri-operative anesthesia, surgery, oncology, and hematology.

[Role of neurosurgical management in movement disorders other than Parkinson disease].

Neurosurgical procedures are indispensable in management of various types of movement disorders (MD). Stereotactic operations that have been well established include deep brain stimulation for tremor, dystonia, and Parkinsonian symptoms. Recently the actual role of stereotactic ablative procedures such as thalamotomy and pallidotomy has been re-explored, and Vo thalamotomy shows long-term improvement of task specific focal dystonia like writer's cramp and musician's dystonia. A new less invasive treatment of tremor using MR guided focused ultrasound has started and is promising. Intrathecal administration of baclofen is also an established treatment for severe spasticity, but other ablative procedures such as peripheral neurotomy and dorsal rhizotomy are also important in spasticity treatment. It seems that most neurologists are unfamiliar, at least in Japan, with such neurosurgical procedures. However, neurologists involved in management of MD should understand the important roles of neurosurgical management of intractable MD and should refer such patients to appropriate neurosurgeons before permanent contracture and deformity develop.

[Non-medicinal treatments of spasticity in multiple sclerosis]. / Traitements non médicamenteux de la spasticité dans la sclérose en plaques.

Non-medicinal treatments of spasticity may be proposed in patients with multiple sclerosis as either an adjunct to pharmacological treatments or the first line of treatment. Assessment of non-medicinal treatments, whether manual, surgical or with instrumentation, shows it to be beneficial for limb spasticity. Studies also reveal that, contrary to expectations, physical exercise does not increase spasticity. This means that physical exercise may be prioritized and that sports practice should not be forbidden, provided that the patient has an adequate neurological status and takes sufficient breaks to avoid fatigue.

[Neurosurgery of the spasticity syndrome in children cerebral palsy].

The review is devoted to main neurosurgical approaches to the treatment of the spasticity syndrome in children cerebral palsy. Neurosurgical procedures are divided into destructive and neuromodulating. The former included posterior selective rhizotomy, selective neurotomy and destructive operations on subcortical brain structures. The latter group included electrostimulation of brain and spinal cord structures and implantation of pumps for the chronic intrathecal baclofen (lioresal) infusion. Each method is considered in a historical aspect. Details of clinical application, positive and negative sides of the methods are described.

Percutaneous radiofrequency lesions adjacent to the dorsal root ganglion alleviate spasticity and pain in children with cerebral palsy: pilot study in 17 patients.

BACKGROUND: Cerebral palsy (CP) may cause severe spasticity, requiring neurosurgical procedures. The most common neurosurgical procedures are continuous infusion of intrathecal baclofen and selective dorsal rhizotomy. Both are invasive and complex procedures. We hypothesized that a percutaneous radiofrequency lesion of the dorsal root ganglion (RF-DRG) could be a simple and safe alternative treatment. We undertook a pilot study to test this hypothesis. METHODS: We performed an RF-DRG procedure in 17 consecutive CP patients with severe hip flexor/adductor spasms accompanied by pain or care-giving difficulties. Six children were systematically evaluated at baseline, and 1 month and 6 months after treatment by means of the Modified Ashworth Scale (MAS), Gross Motor Function Measure (GMFM) and a self-made caregiver's questionnaire. Eleven subsequent children were evaluated using a Visual Analogue Scale (VAS) for spasticity, pain and ease of care. RESULTS: A total of 19 RF-DRG treatments were performed in 17 patients. We found a small improvement in muscle tone measured by MAS, but no effect on the GMFM scale. Despite this, the caregivers of these six treated children unanimously stated that the quality of life of their children had indeed improved after the RF-DRG. In the subsequent 11 children we found improvements in all VAS scores, in a range comparable to the conventional treatment options. CONCLUSION: RF-DRG is a promising new treatment option for severe spasticity in CP patients, and its definitive effectiveness remains to be defined in a randomised controlled trial.

Cirurgias e intervenções físicas no tratamento da espasticidade na paralisia cerebral / Surgeries and physical interventions in the treatment of cerebral palsy spasticity

Apesar de o tratamento da espasticidade em pacientes com paralisia cerebral fundamentar-se, essencialmente, na cinesioterapia e medicamentos administrados como infiltrações ou por via oral, ocorrem situações nas quais tais intervenções não surtem os efeitos desejados, seja em virtude da gravidade da espasticidade ou da contra-indicação e efeitos adversos ao uso da toxina botulínica. Também podem ocorrer distorções do aparelho locomotor resultantes do constante estímulo deformante da espasticidade e da alteração biomecânica que ela impõe ao posicionamento de membros durante a marcha, ortostatismo ou outras posições de repouso. Nestas últimas situações, estão indicados procedimentos cirúrgicos que visam a melhoria da condição biomecânica, adequação do posicionamento e maior eficiência da movimentação em geral. Este artigo de revisão tem por objetivo apresentar as formas alternativas de administração de drogas para o controle da espasticidade, como a bomba de baclofeno, cujo implante exige procedimento cirúrgico, outras indicações e intervenções cirúrgicas para o controle da espasticidade e de suas conseqüências como deformidades e alteração de função além de procedimentos fisioterápicos e uso de órteses sempre com o objetivo de redução dos quadros espásticos.

Although the espasticidade treatment in patients with cerebral palsy is based essentially on cinesioterapia and drugs administrated as chemical blockades infiltration or orally, there are situations where such aid does not have the desired effect, either because of the seriousness of the espasticidade or contra-indications and adverse effects of the botulinum toxin. We can also see human musculoskeletal apparatus deformities resulting from constant deforming stimulus of espasticidade and amendment biomechanics that it imposes on the member positioning during the gait, ortostatismo or other rest positions. In this situation, are indicated surgical procedures which aim at improving the condition of positioning biomechanics, adequacy and efficiency of movement in general. This review article has the aim to provide alternative forms of drug administration for the control of espasticidade, as baclofen bump that requires a chirurgical procedure and others indications and surgeries for the control of espasticidade and its consequences as deformities. We will discuss also the indications for physiotherapy procedures and ortheses indications with the indication to reduce spasticity.

[Selective cervical dorsal root cutting off part of the vertebral lateral mass fixation combined with exercise therapy for treating spastic cerebral paralysis of the upper limbs caused by cerebral palsy].

OBJECTIVE: To explore the feasibility and the result for the surgical treatment of spastic cerebral paralysis of the upper limbs in patients who underwent the selective cervical dorsal root cutting off part of the vertebral lateral mass fixation combined with exercise therapy. METHODS: From March 2004 to April 2008, 27 patients included 19 boys and 8 girls, aging 13-21 years with an average of 15 years underwent selective cervical dorsal root cutting off part of the vertebral lateral mass fixation with exercise therapy. The AXIS 8 holes titanium plate was inserted into the lateral mass of spinous process through guidance of the nerve stimulator, choosed fasciculus of low-threshold nerve dorsal root and cut off its 1.5 cm. After two weeks, training exercise therapy was done in patients. Training will include lying position, turning body, sitting position, crawling, kneeling and standing position, walking and so on. Spastic Bobath inhibiting abnormal pattern was done in the whole process of training. The muscular tension, motor function (GMFM), functional independence (WeeFIM) were observed after treatment. RESULTS: All patients were followed up from 4 to 16 months with an average of 6 months. Muscular tension score were respectively 3.30 +/- 0.47 and 1.25 +/- 0.44 before and after treatment;GMFM score were respectively 107.82 +/- 55.17 and 131.28 +/- 46.45; WeeFIM score were respectively 57.61 +/- 25.51 and 87.91 +/- 22.39. There was significant improvement before and after treatment (P < 0.01). CONCLUSION: Selective cervical dorsal root cutting off part of the vertebral lateral mass fixation combined with exercise therapy was used to treat spastic cerebral paralysis of the upper limbs is safe and effective method, which can decrease muscular tension and improve motor function, which deserves more wide use.

Intrathecal baclofen in current neuromodulatory practice: established indications and emerging applications.

Intrathecal baclofen (ITB) has evolved into a standard treatment for severe spasticity of both spinal and cerebral origin. The accumulated promising data from reported series of patients receiving ITB therapy together with the fact that spastic hypertonia commonly coexists with other neurological disorders have constituted a solid basis for offering this kind of treatment to patients suffering from other movement disorders. These include motor disorders such as dystonia, amyotrophic lateral sclerosis, status dystonicus, Hallervorden-Spatz disease, Freidreich's ataxia, "stiff-man" syndrome, but also vegetative states after revere brain trauma, anoxic encephalopathy or other pathology and more recently, various chronic pain syndromes. In this article, on the basis of the established applications of ITB therapy, we review the important emerging indications of this rewarding neuromodulation method and attempt to identify its future potential beneficial role in other chronic and otherwise refractory neurological disorders.

[Preliminary results of treatment for spastic forms of infantile cerebral paralysis by chronic epidural neurostimulation of lumbar enlargement].

Six patients with infantile cerebral paralysis following drug-resistant spastic syndrome were operated on. Four children suffered from lower spastic paraparesis; 2 had spastic tetraparesis. All the children were observed to have leg chiasm and myogenic equinus talipes. Electrodes were implanted under X-ray guidance into the posterior epidural cavity of the spinal cord at the level of Th10-Th12 vertebrae and the MATTRIX system. In the postoperative period, all the children had a steady-state decrease in leg and arm muscle tone during 1-2 daily high-frequency electrostimulation sessions. Within the early week, there was a regression of equinus talipes and leg chiasm. A follow-up indicated a steady-state clinical effect in all the patients. Stimulation myography revealed that the H reflex was suppressed and the H/M ratio decreased to the normal level (60-80%) in all the patients. An average of one daily electrostimulation session was sufficient to maintain muscle tone at the near-normal level.

Neurosurgical treatment of spasticity and other pediatric movement disorders.

For children whose spasticity and movement disorders are inadequately treated by oral medications and botulinum toxins, neurosurgical procedures are now available to effectively treat spasticity, tremor, and many cases of dystonia. Spastic diplegia can be treated with selective lumbar rhizotomies, which significantly decrease spasticity, increase range of motion, and improve Gross Motor Function Measure scores. Children with spastic quadriparesis and those with secondary dystonia can be treated with intrathecal baclofen, which diminishes both spasticity and dystonia and is associated with improved function and quality of life. Children with primary dystonia and those with tremor can be treated with deep brain stimulation of the internal globus pallidus and thalamus, respectively. Some children with chorea respond to deep brain stimulation. There are no effective neurosurgical treatments for athetosis or ataxia. The effectiveness of neurosurgical treatments of pediatric movement disorders has increased significantly in the past 15 years.

The important role of pain in neurorehabilitation. The neurosurgeon's approach or (neurorehabilitation: the neurosurgeon's role with special emphasis on pain and spasticity).

Pain syndromes due to peripheral or central nervous system damage, or both, may hinder neurorehabilitation. Control of pain may be obtained by ablative or augmentative procedures. Of the ablative modes only DREZ and Cordectomy are still being employed in cases of pain due to Brachial Plexus Avulsion and conus and cauda damage at T9-L1: in both pain is not simply due to "deafferentiation". The augmentative procedures include spinal cord, deep brain and cortical stimulation. Subarachnoid infusion of drugs (midazolam, clonidine, baclofen, etc.) is a new avenue open to control pain. Indications, results and mechanisms of action of those procedures in neuropathic pain are discussed on the basis of literature and personal experience.

The surgical management of spasticity.

Neurosurgery is only considered for severe spasticity following the failure of noninvasive management (adequate medical and physical therapy). The patients are carefully selected, based on rigorous multidisciplinary clinical assessment. In this we evaluate the contribution of the spasticity to the disability and any residual voluntary motor function. The goals for each patient are: (a) improvement of function and autonomy; (b) control of pain; and (c) prevention of orthopaedic disorders. To achieve these objectives, the surgical procedure must be selective and reduce the excessive hypertonia without suppressing useful muscle tone and limb functions. The surgical procedures are: (1) Classical neuro-ablative techniques (peripheral neurotomies, dorsal rhizotomies) and their modern modifications using microsurgery and intra-operative neural stimulation (dorsal root entry zone: DREZotomy). These techniques are destructive and irreversible, with the reduced muscle tone reflecting the nerve topography. It is mainly indicated when patients have localized spasticity without useful mobility. (2) Conservative techniques based on a neurophysiological control mechanism. These procedures are totally reversible. The methods involve chronic neurostimulation of the spinal cord or the cerebellum. There are only a few patients for whom this is indicated. Conversely, chronic intrathecal administration of baclofen, using an implantable pump, is well established in the treatment of diffuse spasticity of spinal origin. From reports in the literature, we critically review the respective indications in terms of function, clinical progression and the topographic extent of the spasticity.

Intrathecal baclofen in severe spasticity.

Control of severe spasticity and its associated features with administration of baclofen directly into the CSF via an intrathecal pump has radically improved the management of patients resistant to oral therapy. This article reviews the rationale and clinical indications for this technique, and the outcome and complications encountered.

Selective neurotomy of the tibial nerve for treatment of the spastic foot.

One of the most frequent neurological sequelae seen by the specialist in rehabilitation is the spastic foot. Spasticity in the foot may be responsible for abnormal posture and painful or trophic disturbances impairing standing and walking. This disability can be corrected by a simple neurosurgical procedure, the selective tibial neurotomy. In this procedure, one sections the tibial nerve branches to the muscles sustaining spasticity, i.e., the soleus and/or the gastrocnemius nerves for equinus and ankle clonus or the posterior tibialis branch for varus and the flexor fascicles for tonic flexion of the toes. After microsurgical dissection of each tibial nerve branch at the lower part of the popliteal region and their identification with bipolar electrostimulation, the selected branches are partially sectioned under the operating microscope. The present series consists of 62 operations performed in 53 patients, 9 bilaterally and 44 unilaterally. Operation obtained complete suppression of the disabling spasticity that had been present for 2 to 17 years (4 on average), total pain relief, and consequently improvement of the residual voluntary movements (by achieving a better balance between agonist and antagonist muscles) in 51 of the 62 spastic feet (i.e., 82% of the cases). For all of these patients, the beneficial effects were long-lasting over the 1- to 10-year follow-up (3 years on average). Selective neurotomy of the tibial nerve should be considered only after failure of intensive prolonged kinestherapy and of all available medical treatment. It must take place, however, before the onset of irreversible articular disturbances and musculotendinous retractions, which require complementary orthopedic corrections.

Management of spasticity.

The functional impairment due to spasticity must be carefully assessed before any treatment is considered. Therapeutic intervention is best individualized to a particular patient. Basic principles of treatment to ameliorate spastic hypertonia are: 1) avoid noxious stimuli and 2) provide frequent range of motion. Therapeutic exercise, cold or topical anesthesia may decrease reflex activity for short periods of time in order to facilitate minimal motor function. Casting and splinting techniques are extremely valuable to extend joint range diminished by hypertonicity. Baclofen, diazepam and dantrolene remain the three most commonly used pharmacologic agents in the treatment of spastic hypertonia. Baclofen is generally the drug of choice for spinal cord types of spasticity, while sodium dantrolene is the only agent which acts directly on muscle tissue. Phenytoin with chlorpromazine may be potentially useful if sedation does not limit their use. Tizanidine and ketazolam, not yet available in the United States, may be significant additions to the pharmacologic armamentarium. Intrathecal administration of antispastic medications allows high concentrations of drug near the site of action, which limits side effects. This form of treatment is the most exciting recent development in the treatment of spastic hypertonia. Peripheral electrical stimulation may have limited use in diminishing tone and facilitating paretic muscles. Dorsal column stimulation via electrodes within the spinal column was initially hailed as a therapeutic advance, but has subsequently been shown to be minimally effective. Phenol injections provide a valuable transition between short-term and long-term treatments and offer remediation of hypertonia in selected muscle groups. Tenotomies and tendon transfers offer significant benefit in carefully chosen patients.(ABSTRACT TRUNCATED AT 250 WORDS)